Minimally invasive focused parathyroidectomy without using intraoperative parathyroid hormone monitoring or gamma probe

J Postgrad Med. 2009 Oct-Dec;55(4):242-6. doi: 10.4103/0022-3859.58925.

Abstract

Background: Minimally invasive parathyroidectomy (MIP) is widely used worldwide for the treatment of primary hyperparathyroidism (pHPT). It is usually combined with a perioperative adjunct for high success rate.

Aim: To demonstrate that MIP can be successfully performed in a selected group of patients with presumabally solitary adenoma as the cause of pHPT without using any perioperative adjuncts.

Settings and design: A prospective data analysis of two surgeons' series from a teaching hospital in Turkey.

Materials and methods: Of the 47 patients referred with a diagnosis of pHPT during January 2004-May 2008, 30(63%) patients with sporadic pHPT with presumed solitary adenoma were included for analysis. These patients underwent MIP via focused lateral (n=24) or anterior (n=6) approach. Preoperative localization was done using 99 mTc-labelled sestamibi scan and ultrasonography. Only patients with concordant tests for single adenoma were selected for MIP. Serum parathyroid hormone and calcium levels were measured postoperatively and at follow-up visits.

Statistical analysis: Parametric data presented were analyzed with Excel XP (Microsoft, Redmond, WA, USA).

Results: Barring one patient, all other patients were initially biochemically cured by MIP. One patient remained hypercalcemic, who was found to have a second adenoma at the second operation. During a mean follow-up of 16 (3-55) months, all patients were normocalcemic with a mean serum calcium level of 9.4 (8.9-10.2) mg/dl. Parathormone levels were persistantly elevated only in one patient (3.4%). No postoperative permanent complication was encountered.

Conclusion: The results of MIP achieved in high-volume endocrine surgery centers can be replicated in low-volume center without any intraoperative adjuncts, in patients with overt clinical pHPT and concordant results of sestamibi and ultrasound.

MeSH terms

  • Adenoma / complications
  • Adenoma / diagnostic imaging
  • Adenoma / surgery*
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Hospitals, Teaching
  • Humans
  • Hyperparathyroidism, Primary / diagnostic imaging
  • Hyperparathyroidism, Primary / etiology
  • Hyperparathyroidism, Primary / surgery*
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures / methods*
  • Parathyroid Hormone / blood*
  • Parathyroid Neoplasms / complications
  • Parathyroid Neoplasms / diagnostic imaging
  • Parathyroid Neoplasms / surgery*
  • Parathyroidectomy / methods*
  • Prospective Studies
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Surgery, Computer-Assisted / methods
  • Technetium Tc 99m Sestamibi / administration & dosage
  • Time Factors
  • Treatment Outcome
  • Turkey
  • Ultrasonography

Substances

  • Parathyroid Hormone
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi